Skip to main content
Clinical Trials/NCT02694016
NCT02694016
Terminated
Not Applicable

Remote Ischemic Preconditioning in Patients Undergoing Isolated Aortic Valve Replacement Surgery With a Biological Prosthesis: A Single Center Randomized Prospective Study

Oulu University Hospital1 site in 1 country4 target enrollmentFebruary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic Valve Disease
Sponsor
Oulu University Hospital
Enrollment
4
Locations
1
Primary Endpoint
Neuropsychological assesment
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

The goal is to investigate the efficacy, safety and possible neuro- and cardioprotective effects of remote ischemic preconditioning (RIPC) in adult cardiac patients undergoing isolated aortic valve replacement surgery with a biological prosthesis. Neuropsychological evaluation preoperatively and at 30d after surgery will establish if there are any differences in neuropsychological performance between groups. A large array of biochemical markers will be analyzed from plasma samples taken at different time points. Additionally skin biopsies from the lower limb will be taken before and after performing RIPC on said limb. During the venous cannulation phase a atrial biopsy will be taken. The biochemical markers from plasma and tissue samples will be used to asses brain tissue damage, inflammation and cardiac tissue damage between groups.

This will be a single center prospective randomized study with two groups. A intervention group (RIPC) and a control group. Study size is: 40 patients in total, 20 patients per group.

Registry
clinicaltrials.gov
Start Date
February 2016
End Date
December 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Fredrik Yannopoulos

Resident

Oulu University Hospital

Eligibility Criteria

Inclusion Criteria

  • Non-emergency aortic valve replacement with a biological prosthesis with perfusion and cardiac arrest

Exclusion Criteria

  • Recent myocardial infarction
  • Carotid stenosis requiring intervention
  • Any other concomitant surgical procedure
  • Increased troponin baseline before surgery
  • Critical ischemia of lower limbs
  • Peripheral arterial disease (ASO, media sclerosis)
  • Morbid obesity (Incompatible cuff-to-thigh diameter)
  • Severe heart insufficiency
  • Moderate to severe venous insufficiency lower limbs
  • Recent acute stroke \<90d

Outcomes

Primary Outcomes

Neuropsychological assesment

Time Frame: 1 month postoperatively

Rey Auditory Verbal Learning Test (RAVLT)

Secondary Outcomes

  • Tissue specific markers analysed from plasma(A day before surgery, during surgery, 24hour and 48hour postoperatively)
  • Inflammation markers analysed from plasma and tissue samples(A day before surgery, during surgery, 24hour and 48hour postoperatively)

Study Sites (1)

Loading locations...

Similar Trials